- Bachurin S, Bukatina E, Lermontova N et al (2001) Antihistamine agent Dimebon as a novel neuroprotector and a cognition enhancer. Ann N Y Acad Sci 939:425–435
Article PubMed CAS Google Scholar
- Bachurin SO, Shelkovnikova TA, Ustyugov AA et al (2012) Dimebon slows progression of proteinopathy in gamma-synuclein transgenic mice. Neurotox Res 22:33–42
Article PubMed CAS Google Scholar
- Bachurin SO, Shevtsova EP, Kireeva EG et al (2003) Mitochondria as a target for neurotoxins and neuroprotective agents. Ann N Y Acad Sci 993:334–344; discussion 345–349
Google Scholar
- Barnes CA (1979) Memory deficits associated with senescence: a neurophysiological and behavioral study in the rat. J Comp Physiol Psychol 93:74–104
Article PubMed CAS Google Scholar
- Blau CW, Cowley TR, O’Sullivan J et al (2012) The age-related deficit in LTP is associated with changes in perfusion and blood-brain barrier permeability. Neurobiol Aging 33(5):1005.e23–35
Google Scholar
- Cowley TR, O’Sullivan J, Blau C et al (2012) Rosiglitazone attenuates the age-related changes in astrocytosis and the deficit in LTP. Neurobiol Aging 33:162–175
Article PubMed CAS Google Scholar
- Cox FF, Carney D, Miller AM et al (2012) CD200 fusion protein decreases microglial activation in the hippocampus of aged rats. Brain Behav Immun 26(5):789–796
Google Scholar
- Doody RS, Gavrilova SI, Sano M et al (2008) Effect of dimebon on cognition, activities of daily living, behaviour, and global function in patients with mild-to-moderate Alzheimer’s disease: a randomised, double-blind, placebo-controlled study. Lancet 372:207–215
Article PubMed CAS Google Scholar
- Ferreira R, Santos T, Goncalves J et al (2012) Histamine modulates microglia function. J Neuroinflammation 9:90
Article PubMed Google Scholar
- Giorgetti M, Gibbons JA, Bernales S et al (2010) Cognition-enhancing properties of Dimebon in a rat novel object recognition task are unlikely to be associated with acetylcholinesterase inhibition or N-methyl-D-aspartate receptor antagonism. J Pharmacol Exp Ther 333:748–757
Article PubMed CAS Google Scholar
- Godbout JP, Johnson RW (2009) Age and neuroinflammation: a lifetime of psychoneuroimmune consequences. Immunol Allerg Clin North Am 29:321–337
Article Google Scholar
- Grigor’ev VV, Garibova TL, Voronina TA et al (2009) Effects of chronic administration of dimebon on behavior and memory of SAMP 10 mice. Eksperimental’naia i klinicheskaia farmakologiia 72:52–56
PubMed Google Scholar
- Grigorev VV, Dranyi OA, Bachurin SO (2003) Comparative study of action mechanisms of dimebon and memantine on AMPA- and NMDA-subtypes glutamate receptors in rat cerebral neurons. Bull Exp Biol Med 136:474–477
Article PubMed CAS Google Scholar
- Ionov ID, Severtsev NN (2012) Histamine- and haloperidol-induced catalepsy in aged mice: differential responsiveness to L: -DOPA. Psychopharmacology 223:191–197
Article PubMed CAS Google Scholar
- Jones RW (2010) Dimebon disappointment. Alzheimer’s Res Ther 2:25
Article Google Scholar
- Kelly L, Grehan B, Chiesa AD et al (2011) The polyunsaturated fatty acids, EPA and DPA exert a protective effect in the hippocampus of the aged rat. Neurobiol Aging 32:2318.e1–15
Google Scholar
- Lermontova NN, Lukoyanov NV, Serkova TP et al (2000) Dimebon improves learning in animals with experimental Alzheimer’s disease. Bull Exp Biol Med 129:544–546
Article PubMed CAS Google Scholar
- Lynch MA (2010) Age-related neuroinflammatory changes negatively impact on neuronal function. Front Aging Neurosci 1:6
Article PubMed Google Scholar
- Moreira PI, Zhu X, Wang X et al (2010) Mitochondria: a therapeutic target in neurodegeneration. Biochim Biophys Acta 1802:212–220
Article PubMed CAS Google Scholar
- Rosenzweig ES, Barnes CA (2003) Impact of aging on hippocampal function: plasticity, network dynamics, and cognition. Prog Neurobiol 69:143–179
Article PubMed CAS Google Scholar
- Sachdeva D, Burns A (2011) Dimebolin in Dementia. CNS Neurosci Ther 17(3):199–205
Article PubMed Google Scholar
- Schaffhauser H, Mathiasen JR, Dicamillo A et al (2009) Dimebolin is a 5-HT6 antagonist with acute cognition enhancing activities. Biochem Pharmacol 78:1035–1042
Article PubMed CAS Google Scholar
- Steele JW, Lachenmayer ML, Ju S et al (2012) Latrepirdine improves cognition and arrests progression of neuropathology in an Alzheimer’s mouse model. Mol Psychiatry [Epub ahead of print]
- Terao A, Steininger TL, Morairty SR et al (2004) Age-related changes in histamine receptor mRNA levels in the mouse brain. Neurosci Lett 355:81–84
Article PubMed CAS Google Scholar
- Vanguilder HD, Bixler GV, Brucklacher RM et al (2011) Concurrent hippocampal induction of MHC II pathway components and glial activation with advanced aging is not correlated with cognitive impairment. J Neuroinflammation 8:138
Article PubMed CAS Google Scholar
- Vignisse J, Steinbusch HW, Bolkunov A et al (2011) Dimebon enhances hippocampus-dependent learning in both appetitive and inhibitory memory tasks in mice. Prog Neuropsychopharmacol Biol Psychiatry 35:510–522
Article PubMed CAS Google Scholar
- Vizuete ML, Merino M, Venero JL et al (2000) Histamine infusion induces a selective dopaminergic neuronal death along with an inflammatory reaction in rat substantia nigra. J Neurochem 75:540–552
Article PubMed CAS Google Scholar
- Wang BW, Hok V, Della-Chiesa A et al (2012) Rosiglitazone enhances learning, place cell activity, and synaptic plasticity in middle-aged rats. Neurobiol Aging 33:835.e13–e30
Google Scholar
- Webster SJ, Wilson CA, Lee CH et al (2011) The acute effects of dimebolin, a potential Alzheimer’s disease treatment, on working memory in rhesus monkeys. Br J Pharmacol 164:970–978
Article PubMed CAS Google Scholar
- Wu J, Li Q, Bezprozvanny I (2008) Evaluation of Dimebon in cellular model of Huntington’s disease. Mol Neurodegener 3:15
Article PubMed Google Scholar